Evidence map›Paper›PMID 21350579›Full record

ReviewNature reviews. Immunology2011

Microbial manipulation of receptor crosstalk in innate immunity.

George Hajishengallis, John D Lambris

Open access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 169 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
169citing papers in PubMed, 1 pooled it
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

169 citing papers in PubMed, 1 synthesis or guideline pooled it, 301 citations in OpenAlex.

  1. Pooled it
  2. Effects of Heat-KilledNutrients · 2024
    Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Increased abundance ofOncology letters · 2024
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

109 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

George HajishengallisUniversity of Louisville, Department of Microbiology and Immunology, Louisville, Kentucky 40292, USA. g0haji01@louisville.edu
John D Lambris
University of Louisville · USUniversity of Pennsylvania · US

Funding

Role of complement in kidney disorders: from hemodialysis to transportationP01AI068730 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LAMBRIS, JOHN D · 2007 to 2018
$16.0M
P. gingivalis as a keystone pathogenR01DE015254 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI HAJISHENGALLIS, GEORGIOS · 2004 to 2018
$4.6M
STRUCTURE-FUNCTION ANALYSIS OF DIFFERENT C3 SPECIESR01AI030040 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LAMBRIS, JOHN D · 1993 to 2016
$4.1M
Oral Immunity and Adjuvant ReceptorsR01DE017138 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI HAJISHENGALLIS, GEORGIOS · 2006 to 2014
$3.8M
STRUCTURAL-FUNCTIONAL ANALYSIS OF COMPSTATINR01GM062134 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI LAMBRIS, JOHN D · 2001 to 2010
$2.5M
Thermodynamic and structural studies on the formation of the C3 convertaseR01AI072106 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LAMBRIS, JOHN D · 2007 to 2011
$2.0M
Oral Pathogen Exploitation of Innate Recognition as a Function of AgeR01DE018292 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI HAJISHENGALLIS, GEORGIOS · 2007 to 2011
$1.6M
Aging and novel therapeutic interventions in periodontal diseaseRC4DE021580 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI HAJISHENGALLIS, GEORGIOS · 2010 to 2010
$1.6M
The role of complement in ovarian cancerR01CA112162 · NCI · UNIVERSITY OF PENNSYLVANIA · PI LAMBRIS, JOHN D · 2005 to 2009
$1.5M
Biomaterial-induced complement activationR01EB003968 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI LAMBRIS, JOHN D · 2005 to 2008
$1.0M
VIRAL RESPIRATORY PATHOGENS RESEARCH UNIT /VRPRU/-266030040-266030040N01AI030040 · NIAID · UNIVERSITY OF IOWA · PI APICELLA, MICHAEL A. · 2003 to 2006
–
NCI NIH HHS CA112162NCI NIH HHS R01 CA112162NIAID NIH HHS AI30040NIAID NIH HHS AI68730NIAID NIH HHS AI72106NIAID NIH HHS N01 AI030040NIAID NIH HHS P01 AI068730NIAID NIH HHS R01 AI030040NIAID NIH HHS R01 AI072106NIBIB NIH HHS EB3968NIBIB NIH HHS R01 EB003968NIDCR NIH HHS DE015254NIDCR NIH HHS DE017138NIDCR NIH HHS DE018292NIDCR NIH HHS DE021580NIDCR NIH HHS R01 DE015254NIDCR NIH HHS R01 DE017138NIDCR NIH HHS R01 DE018292NIDCR NIH HHS RC4 DE021580NIGMS NIH HHS GM62134NIGMS NIH HHS R01 GM062134
6 · The paper itself

Abstract

In the arms race of host-microbe co-evolution, successful microbial pathogens have evolved ingenious ways to evade host immune responses. In this Review, we focus on 'crosstalk manipulation' - the microbial strategies that instigate, subvert or disrupt the molecular signalling crosstalk between receptors of the innate immune system. This proactive interference undermines host defences and contributes to microbial adaptive fitness and persistent infections. Understanding how pathogens exploit host receptor crosstalk mechanisms and infiltrate the host signalling network is essential for developing interventions to redirect the host response and achieve protective immunity.

Indexed as

Immunity, InnateAmino Acid MotifsAnimalsBacteriaCandida albicansHost-Pathogen InteractionsHumansMiceModels, ImmunologicalMolecular MimicryReceptor Cross-TalkReceptors, Pattern RecognitionSignal TransductionToll-Like ReceptorsVirusesReceptors, Pattern RecognitionToll-Like Receptors

Identifiers

PMID21350579
PMCPMC3077082
OpenAlexW1968769778

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.